SpaceOAR and Barrigel
SpaceOAR™ Hydrogel
SpaceOAR™ Hydrogel is an absorbable, injectable gel that assists in reducing the radiation dose delivered to the rectum in men undergoing radiation therapy for prostate cancer, thereby decreasing the likelihood of side effects.
Due to the proximity of the prostate to the rectum, prostate radiation therapy can inadvertently cause damage to the rectum, leading to issues such as fecal incontinence or other long-lasting side effects. SpaceOAR™ Hydrogell, an absorbable gel, is inserted through a minimally invasive procedure, creating a temporary space between the prostate and the rectum.
This allows the doctor to complement the patient’s radiation treatment, optimizing cancer targeting while preserving healthy tissue. The hydrogel spacer remains in place for approximately three months. After around six months, the hydrogel is naturally absorbed and cleared from the body through the patient’s urine.
SpaceOAR™ Hydrogel Is Proven To Be Biocompatible
SpaceOARtm hydrogele is FDA approved for patients receiving radiation therapy for prostate cancer
Center of Excellence for SpaceOAR Vue Placement
Dr. Tan's practice has been designated a Boston Scientific Center of Excellence for SpaceOAR™ placement.